Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1260092-44-1
1365655-91-9
756525-91-4
882847-13-4
1347750-75-7
1347750-78-0
1949793-62-7 | (2-[2-(2-(2-[2-(Toluene-4-sulfonyloxy)-ethoxy]-ethoxy)-ethoxy)-ethoxy]-ethoxy)-acetic acid tert-butyl ester | AA019EBH | MFCD30828689
150152-65-1 | BDP TR NHS ester | AA019EFL | MFCD31580120
187754-47-8 | 9-(2-Bromobenzyl)-9h-fluorene | AA019EIW | MFCD07435370
848482-82-6 | 3-chloro-4-((6-methylpyridin-3-yl)oxy)aniline | AA019ELS | MFCD12973649
866615-27-2 | 3-benzyl-3-azabicyclo[3.3.1]nonan-9-ol | AA019EP9 | MFCD13806412
1360944-09-7 | Dimethyl 3-(trifluoromethyl)pyridine-2,5-dicarboxylate | AA019ESG | MFCD31652783
1605138-92-8 | (2-Chloro-4-nitrophenyl)(piperazin-1-yl)methanone hydrochloride | AA019EV5 | MFCD28992020
1064048-70-9 | tert-Butyl ((1-benzhydrylazetidin-3-yl)methyl)(methyl)carbamate | AA019EYK | MFCD30185068
113777-40-5 | MDL 72832 HCl | AA019FRW | MFCD00209915
1235440-72-8 | tert-butyl N-[3-(chloromethyl)-5-(trifluoromethyl)phenyl]carbamate | AA019G9V | MFCD15209579